Tribunal rules in favor of Assessee on revenue expenditure treatment, dismisses Revenue's appeal.

The Tribunal allowed the Assessee's appeal regarding the treatment of expenditure on Membrane Cells as revenue expenditure, overturning the disallowance of Rs. 2,28,91,059. Additionally, the Tribunal set aside the adjustment of Rs. 4,63,88,745 as prior period expenses made by the CIT(A), ruling in favor of the Assessee. The Revenue's appeal challenging the deletion of the adjustment was dismissed by the Tribunal due to the CIT(A) actually confirming the adjustment.

---

---

Issues involved:
The judgment involves two main issues:
1. Treatment of expenditure incurred on replacement of Membrane Cells as revenue or capital in nature.
2. Adjustment of prior period expenses in the computation of book profits under Section 115JB of the Income Tax Act.

Issue 1: Treatment of Expenditure on Membrane Cells:
The appeal by the Assessee challenges the disallowance of Rs. 2,28,91,059 for replacement of Membrane Cells, treated as capital expenditure. The Assessee argued that the replacement was part of ordinary business and should be considered revenue expenditure. The Assessee relied on past decisions by ITAT, High Court, and Supreme Court where similar expenses were allowed as revenue. Despite the Assessee's contentions, the CIT(A) upheld the disallowance. The Tribunal found in favor of the Assessee, noting that the issue was previously decided in the Assessee's favor by various judicial authorities, hence allowing the appeal.

Issue 2: Adjustment of Prior Period Expenses:
The second issue pertains to the addition of Rs. 4,63,88,745 as prior period expenses in the computation of book profits under Section 115JB. The Assessing Officer disallowed the expenses, but the CIT(A) disagreed, stating that the expenses were crystallized during the year and should be considered as prior period expenses. However, the Tribunal found that the CIT(A) confirmed the adjustment despite acknowledging that the expenses did not qualify as prior period expenses. Consequently, the adjustment made by the CIT(A) was set aside, and the Assessee's appeal was allowed.

Separate Judgement:
The Revenue's appeal challenged the deletion of adjustment for prior period expenses. However, the Tribunal noted that the CIT(A) had actually confirmed this adjustment, contradicting the grounds raised by the Revenue. As a result, the Revenue's appeal was dismissed.

In conclusion, the Tribunal allowed the Assessee's appeal regarding the treatment of expenditure on Membrane Cells and the adjustment of prior period expenses, while dismissing the Revenue's appeal.

---